ALK alterations, namely inversions and intragenic deletions, as well as ALK protein overexpression seen via IHC, commonly co-occur with TFCP2 fusion [15], and the upregulation of ALK activity leads to increased cell proliferation and migration in multiple cancer types [22]. The gene discussed is ALK; the disease is cancer.